BACKGROUND: Microbial cell-free DNA (mcfDNA) sequencing of plasma can identify the presence of a pathogen in a host. In this study, we evaluated the duration of pathogen detection by mcfDNA sequencing vs conventional blood culture in patients with bacteremia. METHODS: Blood samples from patients with culture-confirmed bloodstream infection were collected within 24 hours of the index positive blood culture and 48 to 72 hours thereafter. mcfDNA was extracted from plasma, and next-generation sequencing was applied. Reads were aligned against a curated pathogen database. Statistical significance was defined with Bonferroni adjustment for multiple comparisons (P < .0033). RESULTS: A total of 175 patients with Staphylococcus aureus bacteremia (n = 66), gram-negative bacteremia (n = 74), or noninfected controls (n = 35) were enrolled. The overall sensitivity of mcfDNA sequencing compared with index blood culture was 89.3% (125 of 140), and the specificity was 74.3%. Among patients with bacteremia, pathogen-specific mcfDNA remained detectable for significantly longer than conventional blood cultures (median 15 days vs 2 days; P < .0001). Each additional day of mcfDNA detection significantly increased the odds of metastatic infection (odds ratio, 2.89; 95% confidence interval, 1.53-5.46; P = .0011). CONCLUSIONS: Pathogen mcfDNA identified the bacterial etiology of bloodstream infection for a significantly longer interval than conventional cultures, and its duration of detection was associated with increased risk for metastatic infection. mcfDNA could play a role in the diagnosis of partially treated endovascular infections.
BACKGROUND: Microbial cell-free DNA (mcfDNA) sequencing of plasma can identify the presence of a pathogen in a host. In this study, we evaluated the duration of pathogen detection by mcfDNA sequencing vs conventional blood culture in patients with bacteremia. METHODS: Blood samples from patients with culture-confirmed bloodstream infection were collected within 24 hours of the index positive blood culture and 48 to 72 hours thereafter. mcfDNA was extracted from plasma, and next-generation sequencing was applied. Reads were aligned against a curated pathogen database. Statistical significance was defined with Bonferroni adjustment for multiple comparisons (P < .0033). RESULTS: A total of 175 patients with Staphylococcus aureus bacteremia (n = 66), gram-negative bacteremia (n = 74), or noninfected controls (n = 35) were enrolled. The overall sensitivity of mcfDNA sequencing compared with index blood culture was 89.3% (125 of 140), and the specificity was 74.3%. Among patients with bacteremia, pathogen-specific mcfDNA remained detectable for significantly longer than conventional blood cultures (median 15 days vs 2 days; P < .0001). Each additional day of mcfDNA detection significantly increased the odds of metastatic infection (odds ratio, 2.89; 95% confidence interval, 1.53-5.46; P = .0011). CONCLUSIONS: Pathogen mcfDNA identified the bacterial etiology of bloodstream infection for a significantly longer interval than conventional cultures, and its duration of detection was associated with increased risk for metastatic infection. mcfDNA could play a role in the diagnosis of partially treated endovascular infections.
Authors: J Garnacho-Montero; A Gutiérrez-Pizarraya; A Escoresca-Ortega; Y Corcia-Palomo; Esperanza Fernández-Delgado; I Herrera-Melero; C Ortiz-Leyba; J A Márquez-Vácaro Journal: Intensive Care Med Date: 2013-09-12 Impact factor: 17.440
Authors: Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert Journal: Circulation Date: 2015-09-15 Impact factor: 29.690
Authors: N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton Journal: Ann Intern Med Date: 2002-11-19 Impact factor: 25.391
Authors: A K Gopal; V G Fowler; M Shah; D Gesty-Palmer; K A Marr; R S McClelland; L K Kong; G S Gottlieb; K Lanclos; J Li; D J Sexton; G R Corey Journal: J Clin Oncol Date: 2000-03 Impact factor: 44.544
Authors: Maria Souli; Felicia Ruffin; Seong-Ho Choi; Lawrence P Park; Shengli Gao; Nicholas Christopoulos Lent; Batu K Sharma-Kuinkel; Joshua T Thaden; Stacey A Maskarinec; Lisa Wanda; Jonathan Hill-Rorie; Bobby Warren; Brenda Hansen; Vance G Fowler Journal: Clin Infect Dis Date: 2019-11-13 Impact factor: 9.079
Authors: Timothy A Blauwkamp; Simone Thair; Judith C Wilber; Samuel Yang; Michael J Rosen; Lily Blair; Martin S Lindner; Igor D Vilfan; Trupti Kawli; Fred C Christians; Shivkumar Venkatasubrahmanyam; Gregory D Wall; Anita Cheung; Zoë N Rogers; Galit Meshulam-Simon; Liza Huijse; Sanjeev Balakrishnan; James V Quinn; Desiree Hollemon; David K Hong; Marla Lay Vaughn; Mickey Kertesz; Sivan Bercovici Journal: Nat Microbiol Date: 2019-02-11 Impact factor: 17.745
Authors: Peter B Lockhart; Michael T Brennan; Howell C Sasser; Philip C Fox; Bruce J Paster; Farah K Bahrani-Mougeot Journal: Circulation Date: 2008-06-09 Impact factor: 29.690
Authors: Silke Grumaz; Christian Grumaz; Yevhen Vainshtein; Philip Stevens; Karolina Glanz; Sebastian O Decker; Stefan Hofer; Markus A Weigand; Thorsten Brenner; Kai Sohn Journal: Crit Care Med Date: 2019-05 Impact factor: 7.598
Authors: Lauge Farnaes; Julianne Wilke; Kathleen Ryan Loker; John S Bradley; Christopher R Cannavino; David K Hong; Alice Pong; Jennifer Foley; Nicole G Coufal Journal: Diagn Microbiol Infect Dis Date: 2019-02-02 Impact factor: 2.803
Authors: Laure Flurin; Matthew J Wolf; Cody R Fisher; Edison J Cano Cevallos; James J Vaillant; Bobbi S Pritt; Daniel C DeSimone; Robin Patel Journal: J Clin Microbiol Date: 2022-08-30 Impact factor: 11.677